Stem cells are special because they can do two things no other cell in your body can: make copies of themselves indefinitely and transform into completely different cell types. Every other cell in your body is a specialist. A heart muscle cell stays a heart muscle cell. A red blood cell stays a red blood cell. Stem cells are the exception, sitting in a kind of biological holding pattern until they’re called on to become something specific.
Self-Renewal and Differentiation
The two defining properties of stem cells are self-renewal and differentiation. Self-renewal means a stem cell can divide and produce new copies of itself without losing its identity. Most cells in your body can only divide a limited number of times before they wear out or become damaged. Stem cells sidestep this limitation, at least partially, by maintaining their core characteristics through repeated rounds of division.
Differentiation is the process of becoming a specialized cell. A single stem cell in your bone marrow, for example, can give rise to red blood cells, white blood cells, and platelets. This isn’t a one-step transformation. The stem cell first produces intermediate cells called progenitors, which progressively narrow their identity until they become fully mature, functional cells. What makes this remarkable is that the original stem cell can keep doing this for years, replenishing your tissues while never fully committing to a specialized role itself.
Not All Stem Cells Are Equal
Stem cells exist on a spectrum of flexibility, often described as their “potency.” At the top sits the fertilized egg, or zygote, which is the only truly totipotent cell. It can produce every cell type in the body plus the placenta and other support tissues needed during pregnancy. No other cell can do this.
Pluripotent stem cells, like those found in early embryos, are one step down. They can become any cell type in an adult body (heart, brain, liver, skin) but cannot form placental tissue. This makes them enormously versatile and the focus of most regenerative medicine research.
Multipotent stem cells are more restricted. They can produce several cell types, but only within a related family. Blood-forming stem cells in your bone marrow are a classic example: they generate all the different blood and immune cells, but they won’t become neurons or skin cells. Neural stem cells in the brain work the same way, producing neurons and support cells but nothing outside that lineage. To qualify as multipotent, a stem cell must generate at least two distinct cell types from the same developmental family.
Where Stem Cells Live in Your Body
Adult stem cells don’t float freely through your bloodstream. They reside in highly specific microenvironments called niches, which act like protective command centers. The niche is a dynamic network of neighboring cells, physical structures, and chemical signals that together dictate what a stem cell does at any given moment: stay dormant, divide, or begin differentiating.
Most of the time, adult stem cells sit in a quiescent, or resting, state. This dormancy is actually critical to their longevity. By staying quiet, they avoid the DNA damage that comes with frequent cell division. The niche enforces this rest through a combination of direct cell-to-cell contact, signals from the surrounding tissue scaffold, and soluble chemical messengers. When tissue is injured or worn down, the niche signals shift, nudging the stem cell out of dormancy and into action. The components of each niche differ depending on the tissue (bone marrow niches look nothing like intestinal niches), but they all serve the same purpose: keeping stem cells functional and available for when the body needs repair.
A Built-In Advantage for Longevity
One reason stem cells can keep dividing long after other cells have stopped comes down to how they handle their chromosomes. Every time a normal cell divides, the protective caps on the ends of its chromosomes, called telomeres, get a little shorter. Eventually they become so short that the cell stops dividing or self-destructs. This is a central mechanism of cellular aging.
Embryonic stem cells counteract this by producing high levels of telomerase, an enzyme that rebuilds those protective caps after each division. This is why embryonic stem cells are considered essentially immortal in a lab setting: they can divide indefinitely without their chromosomes degrading. Adult stem cells also produce telomerase, but at much lower levels. Low telomerase activity has been detected in stem cells from bone marrow, brain, skin, intestinal lining, pancreas, kidney, and other organs. The result is that adult stem cells do experience telomere shortening over time, just at a slower rate than ordinary cells. This slower clock helps explain why your bone marrow can still produce blood cells decades into life, even as other tissues gradually decline.
Embryonic vs. Adult Stem Cells
Embryonic stem cells come from blastocysts, the hollow ball of cells that forms a few days after fertilization. Their chief advantage is pluripotency: they can become virtually any cell type in the adult body. This makes them powerful tools for studying development and, potentially, for replacing damaged tissue in diseases like Parkinson’s, Alzheimer’s, diabetes, and spinal cord injury.
Adult stem cells are scattered throughout your body in tissues like bone marrow, the brain, the gut lining, and skin. Their primary job is maintenance and repair of the tissue they reside in. They’re more limited in what they can become, typically producing only cell types related to their home tissue. There is some evidence that adult stem cells can occasionally cross lineage boundaries and produce unrelated cell types, but this flexibility is far more restricted than what embryonic cells offer. Adult stem cells are also harder to isolate and grow in the lab, which limits their practical use in some therapeutic settings.
Reprogramming: Turning the Clock Back
In 2006, researchers demonstrated something that reshaped the entire field: ordinary adult cells could be reprogrammed back into a stem-cell-like state. By introducing four specific proteins into regular skin cells, Shinya Yamanaka’s team reversed their specialization and created what are now called induced pluripotent stem cells, or iPSCs. This discovery earned a Nobel Prize and opened a new path for medicine.
iPSCs behave much like embryonic stem cells. They can self-renew and differentiate into a wide range of cell types. But because they can be made from a patient’s own cells, they sidestep two major problems. First, there’s no need for embryonic tissue, which removes the ethical concerns that have surrounded embryonic stem cell research for decades. Second, because iPSCs carry the patient’s own DNA, transplanted cells are far less likely to be rejected by the immune system. This makes iPSCs a uniquely scalable platform for studying inherited diseases, modeling how specific conditions develop at the cellular level, and eventually replacing damaged cells in clinical treatment.
Where Stem Cell Therapies Stand Today
Despite the enormous potential, approved stem cell therapies remain relatively narrow. The most established treatments involve blood-forming stem cells from bone marrow or umbilical cord blood. The FDA has approved several cord blood products for conditions where patients need to rebuild their blood and immune systems, such as after chemotherapy or for certain blood disorders. One approved product, remestemcel-L, uses mesenchymal stem cells (a type of adult stem cell) for a specific inflammatory condition in children.
Beyond these approved therapies, research is expanding rapidly. As of December 2024, a major review identified 115 clinical trials worldwide involving 83 distinct products derived from pluripotent stem cells. The most active areas of investigation are eye diseases, neurological conditions, and cancer. The number of these trials is growing in 2025, suggesting the gap between laboratory promise and clinical reality is slowly narrowing, even if most applications are still years from routine use.